Barbara Cellini received her degree in Biological Sciences at the University of Urbino (Italy) in 2000 and then a PhD in Biochemical Sciences at the University of Verona (Italy). From 2005 to 2016, she was appointed as an assistant professor of biochemistry at the University of Verona. Since 2017, she has been an associate professor of biochemistry at the University of Perugia (Italy). She contributed to the study of cystalysin, a virulence factor produced by Treponema denticola, and of Dopa decarboxylase, an enzyme involved in Parkinson’s disease, a neurodegenerative disorder, and in AADC deficiency, a neurometabolic disorder. Her research interests are mainly focused on (i) the study of the action of Vitamin B6 administration in Primary Hyperoxaluria Type I as well as the development of new therapeutic approaches for the disease based on either the use of molecules acting as pharmacological chaperones or enzyme administration strategies, and (ii) the elucidation of the biochemical properties of ornithine aminotransferase, whose deficit causes gyrate atrophy of the choroid and retina. In addition, She has been the coordinator of a project on the molecular bases of severe congenital neutropenia, as well as of a project on the development of non-invasive methods for embryo selection in collaboration with a private clinic for in vitro fertilization.